Aurobindo Pharma schedules Q2 FY27 and H1 FY27 earnings call

Board & Shareholder Meetings View source PDF Explain this filing

AUROPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.2%Reaction day

₹1571.70

prior close

₹1576.30

announcement price

In-mkt

timing

Nifty Midcap 150market+1.1%+0.1% vs market

Pharmaceuticals peers, median of 174sector+1.2%-0.0% vs sector

On the reaction day the stock moved 0.1 pts more than Nifty Midcap 150 and in line with its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.1

10m

+0.2

15m

+0.1

30m

+0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.2+1.1+0.1+1.2-0.0

Next day

+3.6pendingpending+3.1+0.4

—————

15d

—————

UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 174Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Aurobindo Pharma will hold an investor earnings call on November 5, 2026 at 8:30 AM IST to discuss unaudited results for the second quarter and half year ended September 30, 2026. The presentation will be posted on the company website after the results.

Likely market impact

The filing contains no financial results yet. The call and later presentation may help investors assess performance, but no immediate fundamental signal is provided.